E
KURA icon

Ergoteles’s Kura Oncology KURA Stock Holding History

Ergoteles’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-27,404
Closed -$340K – 1520
2022
Q4 		$340K Buy
+27,404
New +$398K 0.01% 866
2022
Q2 		– Sell
-32,159
Closed -$517K – 1833
2022
Q1 		$517K Sell
32,159
-4,039
-11% -$58.3K 0.02% 648
2021
Q4 		$507K Buy
36,198
+21,524
+147% +$349K 0.02% 634
2021
Q3 		$275K Sell
14,674
-3,126
-18% -$58.9K 0.01% 844
2021
Q2 		$371K Buy
17,800
+3,000
+20% +$74.5K 0.01% 957
2021
Q1 		$418K Buy
+14,800
New +$468K 0.01% 522

Other funds holding KURA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Ergoteles's KURA Position: Q1 2023 in Review

Ergoteles sold out of Kura Oncology (KURA) in Q1 2023, closing a stake of 27,404 shares — an estimated $340K sold.

Ergoteles first reported a position in KURA in Q1 2021 and held it in 6 quarters. The position peaked at $517K in Q1 2022. 141 funds tracked by Wall St. Rank hold KURA as of Q1 2023.

  • Ergoteles reported no remaining Kura Oncology position as of Q1 2023 after selling out during the quarter.
  • Ergoteles sold 27,404 Kura Oncology shares in Q1 2023, an estimated $340K.
  • Ergoteles first reported a position in Kura Oncology in Q1 2021 and held it in 6 quarters.
  • Ergoteles's Kura Oncology position peaked at $517K in Q1 2022.
  • 141 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.